Candel Therapeutics Inc <CADL.O>: Stifel initiates coverage with buy rating; target price $22
CADL•Related News
Raymond James lifts PTs for US refiners, sees strong Q2 results
XLE•
KKR: BMO Cuts Target Price to $112 From $120
KKR•
White House to rally utilities, data centers for AI power cost pledge, sources say
XLU•
Ares Management Corp <ARES.N>: BMO raises target price to $128 from $125
ARES•
Ovintiv Inc <OVV.N>: Truist Securities cuts target price to $66 from $70
OVV•